open access
Online first
Letter to the Editor
Published online: 2022-11-24
Get Citation
Coronary microvascular dysfunction in the context of long COVID-19: What is the effect of anti-inflammatory treatment?
Patoulias Dimitrios1, Athina Dimosiari1, Theodoros Michailidis2
Affiliations- Department of Internal Medicine, European Interbalkan Medical Center, Thessaloniki, Greece
- 2nd Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital “Hippokration”, Thessaloniki, Greece
open access
Online first
Letter to the Editor
Published online: 2022-11-24
Abstract
Not available
Abstract
Not available
Get Citation
About this articleTitle
Coronary microvascular dysfunction in the context of long COVID-19: What is the effect of anti-inflammatory treatment?
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Letter to the Editor
Published online
2022-11-24
Page views
52
Article views/downloads
111
DOI
10.33963/KP.a2022.0272
Pubmed
Authors
Patoulias Dimitrios
Athina Dimosiari
Theodoros Michailidis
References (5)- Rola P, Włodarczak A, Włodarczak S, et al. Invasive assessment of coronary microvascular dysfunction in patients with long COVID: Outcomes of a pilot study. Kardiol Pol. 2022 [Epub ahead of print].
- Ikonomidis I, Pavlidis G, Katsimbri P, et al. Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function. Clin Res Cardiol. 2019; 108(10): 1093–1101.
- Ikonomidis I, Lekakis JP, Nikolaou M, et al. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation. 2008; 117(20): 2662–2669.
- Holte E, Kleveland O, Ueland T, et al. Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction. Heart. 2017; 103(19): 1521–1527.
- Siemieniuk RAc, Bartoszko JJ, Zeraatkar D, et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020; 370: m2980.
